Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Neothramycins
1. Neothramycins
2. 67298-49-1
3. 3,8-dihydroxy-7-methoxy-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
4. Nsc 285223
5. Neuro_000143
6. 1,2,3,11a-tetrahydro-3,8-dihydroxy-7-methoxy-5h-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one
7. 3,9-dihydroxy-2-methoxy-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one
Molecular Weight | 262.26 g/mol |
---|---|
Molecular Formula | C13H14N2O4 |
XLogP3 | 0.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 262.09535693 g/mol |
Monoisotopic Mass | 262.09535693 g/mol |
Topological Polar Surface Area | 82.4 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
34
PharmaCompass offers a list of Neothramycins API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Neothramycins manufacturer or Neothramycins supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neothramycins manufacturer or Neothramycins supplier.
PharmaCompass also assists you with knowing the Neothramycins API Price utilized in the formulation of products. Neothramycins API Price is not always fixed or binding as the Neothramycins Price is obtained through a variety of data sources. The Neothramycins Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Neothramycins manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neothramycins, including repackagers and relabelers. The FDA regulates Neothramycins manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neothramycins API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Neothramycins supplier is an individual or a company that provides Neothramycins active pharmaceutical ingredient (API) or Neothramycins finished formulations upon request. The Neothramycins suppliers may include Neothramycins API manufacturers, exporters, distributors and traders.
click here to find a list of Neothramycins suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Neothramycins DMF (Drug Master File) is a document detailing the whole manufacturing process of Neothramycins active pharmaceutical ingredient (API) in detail. Different forms of Neothramycins DMFs exist exist since differing nations have different regulations, such as Neothramycins USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Neothramycins DMF submitted to regulatory agencies in the US is known as a USDMF. Neothramycins USDMF includes data on Neothramycins's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Neothramycins USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Neothramycins suppliers with USDMF on PharmaCompass.
Neothramycins Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Neothramycins GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Neothramycins GMP manufacturer or Neothramycins GMP API supplier for your needs.
A Neothramycins CoA (Certificate of Analysis) is a formal document that attests to Neothramycins's compliance with Neothramycins specifications and serves as a tool for batch-level quality control.
Neothramycins CoA mostly includes findings from lab analyses of a specific batch. For each Neothramycins CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Neothramycins may be tested according to a variety of international standards, such as European Pharmacopoeia (Neothramycins EP), Neothramycins JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Neothramycins USP).